Prescient has teamed up with OBS Medical, LTD to form a joint venture company called ViSIG Health, LLC. ViSIG will combine Prescient’s rSIGNIPHY technology with OBS’ Visensia solution to create a novel early warning system tool for intensive care units. Clinical trials with sites in the U.S. and Europe will begin in January 2020.
